Click here to confirm you are a healthcare professionalI am not a healthcare professional. (By clicking on this button you will be taken to an external website).
Case study of a patient with deep response | |
First-line choices for aRCC | |
Best treatment combination for poor-risk patients and how they perform? | |
The best therapeutical approach in the long term, after 18-24 months of therapy, considering the impact on QoL of manageable but bothersome AE | |
What to do with a patient who had not had a prior nephrectomy or evidence of metastatic disease but lesions remain in the kidneys | |
What to expect and aim for? |